How do patents and economic policies affect access to essential medicines in developing countries?
about
A review of the health and economic implications of patent protection, with a specific focus on ThailandTrends in compulsory licensing of pharmaceuticals since the Doha Declaration: a database analysisPatent and exclusivity status of essential medicines for non-communicable diseaseGlossary on the World Trade Organisation and public health: part 2Improving access to medicines in low and middle income countries: corporate responsibilities in contextHow do intellectual property law and international trade agreements affect access to antiretroviral therapy?Are patents impeding medical care and innovation?In which developing countries are patents on essential medicines being filed?International law, public health, and the meanings of pharmaceuticalization.Closing the access gap for health innovations: an open licensing proposal for universitiesA tragically naive Canadian law for tragically neglected global health.Globalization and social determinants of health: Introduction and methodological background (part 1 of 3)Intellectual property and access to medicines: an analysis of legislation in Central America.Patent life of antiretroviral drugs approved in the US from 1987 to 2007.Drug pricing and reimbursement decision making systems in Mongolia.Global Health Governance at a Crossroads.Molecular farming, patents and access to medicines.Basic survival needs and access to medicines--coming to grips with TRIPS: conversion + calculation.Access to controlled medicines for anesthesia and surgical care in low-income countries: a narrative review of international drug control systems and policies.Current Models of Investor State Dispute Settlement Are Bad for Health: The European Union Could Offer an Alternative Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?"Learning from practice: compulsory licensing cases and access to medicines.Delivery of Essential Medicines to Primary Care Institutions and its Association with Procurement Volume and Price: A Case Study in Hubei Province, China.Improving Access to Essential Medicines: How Health Concerns can be Prioritised in the Global Governance System.Recent developments in health law. Essential medicines: why international price discrimination may increasingly be the wrong solution to a global drug problem.Which patent and where? Why international patent transparency by companies is needed for medicines.Ethical issues in transnational "mail order" oocyte donation.Does the pharmaceutical sector have a coresponsibility for the human right to health?The impact of patent protection on US pharmaceutical exports to developing countriesAccess to generic antiretrovirals: inequality, intellectual property law, and international trade agreementsIntellectual Property and Global Health: From Corporate Social Responsibility to the Access to Knowledge Movement
P2860
Q27015946-A5F15906-0A4A-466A-AD47-6740BF597161Q28478773-ED242982-ED18-4812-8B66-1616F1B97641Q28485430-5992062A-40AA-4B85-ADEB-C85984EFD90AQ28756868-2E035CB1-DF27-403E-BAAE-F0A7C14C3A62Q30394023-7421DB1C-0DA5-4420-9623-5979F156D85EQ33252472-F649843F-65B9-4579-9CD0-F8E5D8AC01EBQ33522199-ACAA0684-B0D6-4337-9150-E30F2DF2AF16Q33837177-32F5474A-5582-4D8C-A7CA-DE0AF4FB61D9Q34481901-1BA9523D-90F8-406C-B2A8-D35E712AEA2AQ35633628-CF966EAD-0387-48C9-8CCD-6F0911EE28F4Q35812444-4CDACB09-8F2A-4E77-9348-0B6A15C1AAA3Q35901950-CDF41F24-100C-4A2C-BB6E-B86A0211A474Q37370817-D5AC575C-B116-41E3-BC05-41DE24920B35Q37508820-AFD5ACF3-29C4-43E2-B3F2-620F96FA0013Q37668291-803A59AE-0A47-4D44-A590-86DA925824D7Q37697990-66EC228B-2E4E-4BD1-B8FF-9F7468BA1620Q37776712-4EF9086D-C2C9-4725-B649-8413BA526E08Q37794235-B757B166-5D54-4DD4-83B3-C7EDC2D5CDE5Q39066818-636A3C7F-5F9E-4FD7-8C08-74E329FACBD6Q39235201-B5C4D555-D096-4311-808A-03BB9B647129Q39314613-B32E2EBF-2440-44B5-B052-710614586BA5Q39404874-FD54516E-C6CF-4F96-A3BC-0A65AC4D8E61Q41484867-28D94639-8258-47B7-BED0-ADB6D9C0003DQ44229355-C46EF74D-57DD-4CCB-8DF1-FB2C5AED8A03Q48798421-B4F1F296-CE67-4EA6-9923-780642C153E0Q50644481-B0BD663C-4D6A-4FC1-B160-8AA360F38914Q53044019-90CA51C3-1220-4F54-AB8B-3697A694EFA5Q58253398-A0D79C51-36EB-4B91-9FBB-C03471C3CE82Q58478541-8D22072F-B59F-4546-81BF-E2C7F5352FE3Q58813400-5AD73119-9FF3-4CDE-98C9-B6B7DBFDEF63
P2860
How do patents and economic policies affect access to essential medicines in developing countries?
description
wetenschappelijk artikel
@nl
name
How do patents and economic po ...... cines in developing countries?
@en
How do patents and economic po ...... cines in developing countries?
@nl
type
label
How do patents and economic po ...... cines in developing countries?
@en
How do patents and economic po ...... cines in developing countries?
@nl
prefLabel
How do patents and economic po ...... cines in developing countries?
@en
How do patents and economic po ...... cines in developing countries?
@nl
P356
P1433
P1476
How do patents and economic po ...... cines in developing countries?
@en
P304
P356
10.1377/HLTHAFF.23.3.155